Anti-histone Abs

Other names: Anti-Histone Ab (RDL), HISTONE ANTIBODIES

Optimal result: 0 – 1 Units

Elevated Anti-histone Antibodies (Anti-histone Abs) indicate increased immune reactivity against histone proteins, which are essential components of chromatin within the cell nucleus. These antibodies are part of the antinuclear antibody (ANA) family and reflect abnormal immune activation.

An elevated Anti-histone Antibody result is most commonly associated with the following:

Drug-Induced Lupus Erythematosus (DILE)
Anti-histone antibodies are present in the vast majority of individuals with drug-induced lupus. Certain medications—such as hydralazine, procainamide, minocycline, and others—can trigger antibody production, leading to lupus-like symptoms. In many cases, antibody levels and symptoms improve after discontinuation of the offending drug.

Systemic Autoimmune Conditions
Anti-histone antibodies may also be detected in systemic lupus erythematosus (SLE) and, less commonly, other autoimmune or connective tissue diseases. In these settings, the finding is less specific and must be interpreted alongside other autoimmune markers and clinical features.

An elevated Anti-histone Antibody result does not establish a diagnosis on its own. Clinical correlation—including symptom assessment, medication history, additional autoimmune testing (such as ANA pattern, anti-dsDNA, complement levels), and physician evaluation—is essential to determine its significance.

Histone Antibodies are autoantibodies directed against histone proteins within the cell nucleus. They are most commonly used to help identify drug-induced lupus and to assess immune system activity in certain systemic autoimmune conditions.

Histone antibodies are autoantibodies produced by the immune system that target histones, which are proteins essential for packaging DNA within chromatin in the nuclei of nearly all cells. Because histones are normally located inside cells, the presence of histone antibodies reflects abnormal immune activation and may contribute to systemic autoimmune symptoms.

This test is used to detect histone antibodies in the bloodstream and is most commonly ordered as part of an antinuclear antibody (ANA) evaluation. Histone antibodies represent one subtype of ANA, and identifying specific ANA patterns helps clinicians distinguish between different autoimmune and connective tissue diseases.

Histone antibodies are strongly associated with drug-induced lupus erythematosus (DILE), a lupus-like condition triggered by certain medications. Up to 95% of individuals with drug-induced lupus test positive for histone antibodies. These antibodies may also be present in approximately 50% of patients with systemic lupus erythematosus (SLE) and in up to 20% of individuals with other connective tissue diseases, making clinical context essential for interpretation.

Several medications are known to increase the risk of drug-induced lupus in susceptible individuals. Commonly associated drugs include:

  • Hydralazine

  • Isoniazid

  • Minocycline

  • Penicillamine

  • Procainamide

  • Quinidine

Other medication classes have also been implicated, including certain antibiotics, anti-seizure medications, anti–tumor necrosis factor (TNF) agents, interferon-alpha, blood pressure medications (such as methyldopa), and thyroid medications.

Importantly, drug-induced lupus symptoms and histone antibody levels often improve after the triggering medication is discontinued, distinguishing it from idiopathic autoimmune disease.

Anti-histone Abs
Healthmatters dashboard showing biomarker trend graph

Every lab result you’ve ever had, charted and explained.

Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.

Start with my report →
Beyond Anti-histone Abs — 10,000+ markers explained
One Anti-histone Abs result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.
Start with this report →
Healthmatters timeline preview showing biomarker trends over time
Clinical Sources & References

All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.

Article Review Log
Written by Healthmatters Editorial Team
Healthmatters Lifetime Plan

Pay $250. Track your health forever

One payment. No renewals. Yours for life.

10,000+ biomarkers explained · trends over time

See other plans →
Secure checkout via Stripe · GDPR & HIPAA
We accept results from any lab
LabCorp Quest Diagnostics Genova Diagnostics DUTCH Test Doctor's Data Vibrant America ZRT Laboratory Cyrex Labs + any other lab

What members are saying

★★★★★ 10,000+ happy members
★★★★★

"Watching my numbers move over the years — instead of forgetting last time's results — completely changed how I manage my health."

Daniel
Member since 2022
★★★★★

"Living across several countries made keeping my lab results organized a real challenge. Healthmatters brought my results from the USA, Spain, and Germany together — 20 years of history, with long-term trends instead of scattered reports."

Ben
Member since 2021 · tracks across countries
★★★★★

"Standard lab ranges are too wide for how I practice — 'normal' isn't optimal. I set my own bands, so a client sees yellow before a marker goes officially out of range. That's the conversation I want to be having."

Dr. Alexandra
Functional medicine · 6 yrs on Pro